UNSPSC 51184009: Glipizide

This classification denotes an anti-diabetic agent with the molecular formula C21H27N5O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) X7WDT95N5C, chemically known as urea, 1-cyclohexyl-3-((p-(2-(5-methylpyrazinecarboxamido)ethyl)phenyl)sulfonyl)- but more generally known as glipizide, which bears US NIH Compound Identifier 3478. European Medicines Agency schedules Glipizide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07927MIG.

UNSPSC 51184009 Glipizide, a Commodity code, names a sulfonylurea oral antidiabetic medication that state and local governments procure for public health programs, correctional facilities, and indigent-care systems. The code covers glipizide in all formulations and dosage strengths as a pharmaceutical supply item for chronic disease management in beneficiaries enrolled in state Medicaid programs, county health departments, municipal jails and prisons, and public hospital systems. Procurement under this code typically occurs through state pharmacy benefit managers, centralized purchasing cooperatives, or direct vendor contracts established by state health departments or departments of corrections. Individual jurisdictions also acquire glipizide through national or regional group purchasing organizations (GPOs) that aggregate demand across multiple public agencies.

The source provided contains no recent state and local contract opportunities tagged to this code and no information on issuing bodies, geographic activity, or representative solicitations. Without posted opportunities, current buying patterns under UNSPSC 51184009 cannot be characterized.